Live Breaking News & Updates on Methodist Debakey Heart

Stay updated with breaking news from Methodist debakey heart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

The results are “very comparable” to real-world data, Vinod Thourani said at STS. Others agreed they support SAVR’s safety. ....

San Francisco , United States , West Virginia , University Of California San Francisco , Medstar Washington Hospital Center , District Of Columbia , Vinay Badhwar , Mitroflow Livanova , Vinod Thourani , Elaine Tseng , Michael Reardon , Michael Mack , Thomas Macgillivray , Md University Of California San Francisco , San Francisco Va Medical Centers , Md Baylor Scott White Health , Society Of Thoracic Surgeons , Md Medstar Washington Hospital Center , Md Piedmont Heart Institute , Md Methodist Debakey Heart Vascular Center , Md West Virginia University , Thoracic Surgeons , Adult Cardiac Surgery Database , Piedmont Heart Institute , Baylor Scott , White Health ,

Looking for a Winner Between Long-term TAVI Trials? Don't, Experts Urge

Directly comparing PARTNER 3 and Evolut Low Risk results is like “discussing reincarnation,” one prominent statistician warns. ....

University Hospital , United States , New York , City Of , United Kingdom , Michaela Borger , Davide Capodanno , Medtronic Corevalve , Edwards Lifesciences , Michael Reardon , Eric Van Belle , Forum Gladiators , Presbyterian Columbia University Irving Medical Center , Journal Of The American College Cardiology , Phd Heart Center , Md University Of Oxford , Phd University Of Catania , Md Methodist Debakey Heart Vascular Center , Phd University Hospital , Martin Leon , Columbia University Irving Medical Center , Evolut Low Risk , Methodist Debakey Heart , Vascular Center , New England Journal , American College ,

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

TAVI benefits were attenuated and mortality trended higher in PARTNER 3 at 5 years. For Evolut, TAVI maintained an edge. ....

United States , New York , Gilbert Tang , Pinak Shah , David Cohen , Michael Reardon , Edwards Lifesciences , Kendra Grubb , Bernard Prendergast , Drug Administration , Md Emory University , Presbyterian Columbia University Irving Medical Center , Md Cardiovascular Research Foundation St , Md Methodist Debakey Heart Vascular Center , Journal Of The American College Cardiology , Mount Sinai Health System , Columbia University Irving Medical Center , New England Journal , Emory University , Evolut Low Risk , Methodist Debakey Heart , Vascular Center , Sapien Ultra , Cleveland Clinic London , Cardiovascular Research , Francis Hospital ,

Houston Methodist Sugar Land Hospital performs first new heart failure device implant in Fort Bend County

SUGAR LAND— Houston Methodist Sugar Land Hospital is the first hospital in Fort Bend County to perform a successful implant of Barostim Baroreflex Activation Therapy™, an FDA-approved heart failure device ....

Michaele Debakey , Uttam Tripathy , Houston Methodist Debakey Heart Vascular Center , Heart Vascular Center , Houston Methodist Sugar Land Hospital , Fort Bend County , Barostim Baroreflex Activation Therapy , Houston Methodist Sugar Land , Methodist Debakey Heart , Vascular Center ,

Houston Methodist Sugar Land Hospital performs first new heart failure monitoring device implant in Fort Bend County

SUGAR LAND— Houston Methodist Sugar Land Hospital is the first hospital in Fort Bend County to perform a successful implant of Barostim Baroreflex Activation Therapy™, an FDA-approved heart failure device ....

Michaele Debakey , Uttam Tripathy , Houston Methodist Debakey Heart Vascular Center , Heart Vascular Center , Houston Methodist Sugar Land Hospital , Fort Bend County , Barostim Baroreflex Activation Therapy , Houston Methodist Sugar Land , Methodist Debakey Heart , Vascular Center ,